Suppr超能文献

Is self-sufficiency in haemotherapies a practical or necessary goal?

作者信息

Farrugia Albert, Cassar Josephine

机构信息

School of Medicine, Australian National University, Canberra, Australia.

出版信息

Blood Transfus. 2013 Apr;11(2):183-92. doi: 10.2450/2012.0148-12. Epub 2012 Dec 13.

Abstract
摘要

相似文献

1
Is self-sufficiency in haemotherapies a practical or necessary goal?
Blood Transfus. 2013 Apr;11(2):183-92. doi: 10.2450/2012.0148-12. Epub 2012 Dec 13.
2
Strategic issues currently facing the US blood system.
Transfusion. 2020 May;60(5):1093-1096. doi: 10.1111/trf.15769. Epub 2020 Apr 27.
3
The ethics of blood management.
Vox Sang. 2007 Jul;93(1):91. doi: 10.1111/j.1423-0410.2007.00921.x.
4
Blood and disaster--supply and demand.
N Engl J Med. 2002 Feb 21;346(8):617-20. doi: 10.1056/NEJM200202213460813.
5
The Oslo Blood Bank, 22 July 2011.
Tidsskr Nor Laegeforen. 2011 Dec 13;131(24):2460-1. doi: 10.4045/tidsskr.11.1253.
6
The Market for Blood.
J Econ Perspect. 2014;28(2):177-96. doi: 10.1257/jep.28.2.177.
7
Transfusion services operations during the COVID-19 pandemic: Results from AABB survey.
Transfusion. 2020 Nov;60(11):2760-2762. doi: 10.1111/trf.15986.
8
[Self-sufficiency, needs, prescription and safety of blood products].
Transfus Clin Biol. 2013 May;20(2):139-43. doi: 10.1016/j.tracli.2013.03.004. Epub 2013 Apr 24.
9
Percy Lane Oliver, OBE (1878-1944): founder of the first voluntary blood donor panel.
Transfus Med. 1992 Jun;2(2):159-60. doi: 10.1111/j.1365-3148.1992.tb00150.x.
10
Supply and demand for plasma-derived medicinal products - A critical reassessment amid the COVID-19 pandemic.
Transfusion. 2020 Nov;60(11):2748-2752. doi: 10.1111/trf.16078. Epub 2020 Sep 9.

引用本文的文献

1
Toward a Sociology of Plasma Products.
Int J Soc Determinants Health Health Serv. 2024 Oct;54(4):412-422. doi: 10.1177/27551938241269136. Epub 2024 Aug 14.
3
Toward a patient-based paradigm for blood transfusion.
J Blood Med. 2014 Jan 31;5:5-13. doi: 10.2147/JBM.S55769. eCollection 2014.
4
Modeling primary immunodeficiency disease epidemiology and its treatment to estimate latent therapeutic demand for immunoglobulin.
J Clin Immunol. 2014 Feb;34(2):233-44. doi: 10.1007/s10875-013-9975-1. Epub 2013 Dec 12.
5
Plasma-derived medicinal products self-sufficiency from national plasma: to what extent?
Blood Transfus. 2013 Sep;11 Suppl 4(Suppl 4):s132-7. doi: 10.2450/2013.019s.

本文引用的文献

1
Red blood cell transfusion: a clinical practice guideline from the AABB*.
Ann Intern Med. 2012 Jul 3;157(1):49-58. doi: 10.7326/0003-4819-157-1-201206190-00429.
3
Hemato-nationalism: the past, present, and future of "Japanese blood".
Med Anthropol. 2012;31(2):93-112. doi: 10.1080/01459740.2011.624957.
4
Plasma-derived medicines: access and usage issues.
Blood Transfus. 2012 Jul;10(3):273-8. doi: 10.2450/2011.0118-11. Epub 2012 Dec 21.
5
Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates.
Transfus Med Hemother. 2011;38(1):33-42. doi: 10.1159/000324458. Epub 2011 Jan 31.
7
Moving on from voluntary non-remunerated donors: who is the best blood donor?
Br J Haematol. 2011 Sep;154(6):763-9. doi: 10.1111/j.1365-2141.2011.08708.x. Epub 2011 May 3.
8
How expanding voluntary non-remunerated blood donations would benefit patients, donors and healthcare systems?
Vox Sang. 2011 Aug;101(2):176-7. doi: 10.1111/j.1423-0410.2011.01495.x. Epub 2011 Apr 18.
9

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验